Innovation in Alzheimer’s disease needs more than pharmaceutical solutions Post date 30 April 2026 ← Privatisation: Doctors concerned after private firm is paid £700k to support new NHS neighbourhood health centres → Extrapulmonary tuberculosis is understudied in preventive vaccine trials